AACR-2022 NI-3201 CD28 bispecific antibody platform

On April 5, 2022 The American Association for Cancer Research (AACR) (Free AACR Whitepaper) reported that it will host its Annual Meeting April 8-13, 2022 (Presentation, Light Chain Bioscience, APR 5, 2022, View Source [SID1234611443]). Light Chain Bioscience is very pleased to have Sara Majocchi attend in-person.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Sara will be presenting a poster (#2884) describing Light Chain Bioscience’s CD28-bispecific antibody platform.

"Optimized CD28 bispecific antibodies for targeted activation of T cells within the tumor microenvironment" will be exposed and presented on April 12 between 9:00 a.m -12:30 p.m.

↠ Read poster – Poster section 37: Will be available on website from April 9th.

Ernest N. Morial Convention Center New Orleans, Louisiana

900 Convention Center Blvd, New Orleans, LA 70130, United States